Grim19 Attenuates DSS Induced Colitis in an Animal Model

Abstract

DSS induced colitis is a chronic inflammatory disease characterized by inflammation in the gastrointestinal tract, which destabilizes the gut and induces an uncontrolled immune response. Although DSS induced colitis is generally thought to develop as a result of an abnormally active intestinal immune system, its pathogenesis remains unclear. Gene associated with retinoid interferon induced mortality (Grim) 19 is an endogenous specific inhibitor of STAT3, which regulates the expression of proinflammatory cytokines. In this study, we investigated the influence of GRIM19 in a DSS induced colitis mouse model. We hypothesized that Grim19 would ameliorate DSS induced colitis by altering STAT3 activity and intestinal inflammation. Grim19 ameliorated DSS induced colitis severity and protected intestinal tissue. The expression of STAT3 and proinflammatory cytokines such as IL-1β and TNF-α in colon and lymph nodes was decreased significantly by Grim19. Moreover, DSS induced colitis progression in a Grim19 transgenic mouse line was inhibited in association with a reduction in STAT3 and IL-17 expression. These results suggest that Grim19 attenuates DSS induced colitis by suppressing the excessive inflammatory response mediated by STAT3 activation.

DOI: 10.1371/journal.pone.0155853

Extracted Key Phrases

Cite this paper

@inproceedings{Kim2016Grim19AD, title={Grim19 Attenuates DSS Induced Colitis in an Animal Model}, author={Jae-Kyung Kim and Seung hoon Lee and Seon-Young Lee and Eun-Kyung Kim and Jeong-Eun Kwon and Hyeon-Beom Seo and Han Hee Lee and Bo-In Lee and Sung Hwan Park and Mi-la Cho}, booktitle={PloS one}, year={2016} }